...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
| Page Properties | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| |||||||||
|
...
|
| Page Properties | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
[Disclosure: The senior authors of the NAC study reported here, Drs. LA Herzenberg, both Ph.D., of the Department of Genetics at Stanford University, are on the board of AIDS Treatment News Associates, our nonprofit arm which helps fund newsletter subscriptions for prisoners, persons with low income, and others who cannot pay for copies. The Herzenbergs have a use patent for NAC in the treatment of HIV infection, and have pledged any proceeds to further research.]
...
A placebo-controlled trial in over 60 HIV-positive volunteers found that NAC (N-acetylcysteine) significantly increased abnormally low blood and T-cell levels of glutathione, an important antioxidant found in every cell in the body and essential for life.1 The report was published October 1 in the European Journal of Clinical Investigation.
...